Please prepare journal entries to record the transactions for Beta from 1 December 2019 up to 1 June 2020 with regards to the disposal of a specific machinery. Thank you so much!

Zeta Bio Tech Ltd {Zeta] is engaged in manufacturing of biotechnology products with the below noncurrent assets as at 30 November 2019: Land and buildings Plant and equipment $'000 $'000 Costfrevalued amount 36,000 14,000 Accumulated depreciation I 5501 I 2,1401 Carrying amount 35,450 0,860 Zeta's depreciation policy is 50 years straightline with no residual value for building and warehouse and 3096 reducing balance for plant and equipment. It adopts revaluation model for land and buildings and warehouse; and cost model for plant and equipment in accordance with HKAS 16 'Property, Plant and Equipment'. Zeta opts for transfer from revaluation reserves to retained E' gs only upon derecogmtion. It is also Zeta's policy to revalue the land and buildings on every two years' basis. The end of its repomg' period is 30 November. During the year ended 30 November 2020, Zeta has the following movement on non current assets. (3] On 1 June 2020, Zeta disposed of a specic machinery {under the category of plant and equipment] with a carrying amount of $1.715 million at 1 December 2019 {original cost $3.5 million] for $1.1 million by cheque. Other than the above buildings classied under HKAS 16, Zeta also has a portfolio of buildings (or part of the buildings) treated as investment properlies as at 30 November 2020. They are as follows: (i) Building being selfconstructed for future use as investment property (ii) An unused at let out to directors of Zeta (iii) Former warehouse, unoccupied and no longer required as a warehouse future use to be determined The newly appointed accounting manager of Zeta is not certain about the accounting classication of the above three buildings